http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0903664-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a5364a0c557fcc87e24261395a3f3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89ac64d62baaa791ac712c93832985fd
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D411-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D411-04
filingDate 2009-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c03608fead413b61e0e55a4b87c26ca5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f37b8d9799929ca87dc57870acea892
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53f6cd5c77f1b1cce501b188059af3e2
publicationDate 2020-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0903664-B1
titleOfInvention method of obtaining a new crystalline form of lamivudine, its hydrochloride salt monohydrate, pharmaceutical formulations and their uses
abstract method of obtaining a new crystalline form of lamivudine, its hydrochloride salt monohydrate, pharmaceutical formulations and their uses. the present invention is directed to the method of obtaining a solid crystalline form of lamivudine, form vi, its hydrochloride salt monohydrate and its pharmaceutical formulations. in addition, the present application relates to the use of the crystalline forms of lamivudine monohydrate salt in the preparation of drugs indicated as anti-HIV agent (acquired immunodeficiency syndrome - AIDS).
priorityDate 2009-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409028757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584733
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415732173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21885828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456491257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448478793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86600548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407319186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5210
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451002972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449033654
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9907230

Total number of triples: 54.